ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases
Status:
Not yet recruiting
Trial end date:
2026-02-28
Target enrollment:
Participant gender:
Summary
To determine if the detection of ctDNA after surgical resection of CLM can stratify patients
into high and low-risk cohorts for early disease recurrence in order to inform post-operative
adjuvant therapy.